Locations
Cambridge, MA, USA · Massachusetts, USA · Cambridge, MA, USA · Boston, MA, USA · West Street / River Street, Boston, MA, USA
industry
Biotechnology · DeepTech · Health
Size
11-50 employees
Stage
Other
founded in
2014
Compass Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company leverages its proprietary antibody discovery engine to create a diverse pipeline of monoclonal and multispecific therapeutic candidates aimed at transforming care for patients with cancer and autoimmune diseases. Their innovative approach targets critical biological pathways for effective anti-tumor responses, including angiogenesis modulation and immune response activation. Founded in 2014 and headquartered in Boston, Massachusetts, Compass Therapeutics is positioned to advance its product candidates through clinical development, both as standalone therapies and in combination with other proprietary antibodies, showcasing a strong commitment to improving patient outcomes.
Something looks off?